Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI.
Fiche publication
Date publication
juillet 2017
Journal
Journal of the American College of Cardiology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr LORGIS Luc
Tous les auteurs :
Auffret V, Lefevre T, Van Belle E, Eltchaninoff H, Iung B, Koning R, Motreff P, Leprince P, Verhoye JP, Manigold T, Souteyrand G, Boulmier D, Joly P, Pinaud F, Himbert D, Collet JP, Rioufol G, Ghostine S, Bar O, Dibie A, Champagnac D, Leroux L, Collet F, Teiger E, Darremont O, Folliguet T, Leclercq F, Lhermusier T, Olhmann P, Huret B, Lorgis L, Drogoul L, Bertrand B, Spaulding C, Quilliet L, Cuisset T, Delomez M, Beygui F, Claudel JP, Hepp A, Jegou A, Gommeaux A, Mirode A, Christiaens L, Christophe C, Cassat C, Metz D, Mangin L, Isaaz K, Jacquemin L, Guyon P, Pouillot C, Makowski S, Bataille V, Rodés-Cabau J, Gilard M, Le Breton H,
Lien Pubmed
Résumé
Transcatheter aortic valve replacement (TAVR) is standard therapy for patients with severe aortic stenosis who are at high surgical risk. However, national data regarding procedural characteristics and clinical outcomes over time are limited.
Mots clés
Aged, 80 and over, Aortic Valve Stenosis, diagnosis, Echocardiography, Transesophageal, Female, Follow-Up Studies, France, epidemiology, Humans, Incidence, Male, Prognosis, Prospective Studies, Registries, Survival Rate, trends, Time Factors, Transcatheter Aortic Valve Replacement, trends
Référence
J. Am. Coll. Cardiol.. 2017 Jul 4;70(1):42-55